Industry

Hurdle Health and Blue Cross and Blue Shield of Minnesota Begin Partnership Focused on Culturally Responsive Mental Health Care

Brooklyn Center residents given greater holistic care access as part of five-year place-based partnership EAGAN, Minn.–(BUSINESS WIRE)–Hurdle Health today announced a partnership with Blue Cross and Blue Shield of Minnesota (Blue Cross) to provide free culturally responsive mental healthcare to residents of Brooklyn Center. Traditional forms of therapy are not designed with cultural humility in … [Read more…]

908 Devices to Report Second Quarter 2022 Financial Results on August 9, 2022

BOSTON–(BUSINESS WIRE)–908 Devices Inc., (Nasdaq: MASS) a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will report financial results for the second quarter 2022 before market open on Tuesday, August 9, 2022. Company management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time … [Read more…]

Biodesix to Report Second Quarter 2022 Financial Results on August 4, 2022

BOULDER, Colo.–(BUSINESS WIRE)–$BDSX #patientsfirst—Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus on lung disease, today announced that it will release financial results for the second quarter ended June 30, 2022 before the open of trading on Thursday, August 4. Biodesix’s management will host a conference call and webcast to discuss … [Read more…]

Covac Global Redefines Duty of Care With No Hospitalization Requirement for Repatriation and Newly-added Coverage for Monkeypox

‘No hospitalizations. No nearest. No excuses.’ WEST PALM BEACH, Fla.–(BUSINESS WIRE)–#covid19—Covac Global, the Premier Medical Evacuation Membership, pioneered the simple approach to medical evacuation with “Get Sick, Get Home” requiring no hospitalization, announces it will include repatriation for monkeypox to complement their pioneering medical evacuation memberships – regardless of the location of a traveler’s injury … [Read more…]

Dexcom Canada Achieves Great Place to Work® Certification

BURNABY, British Columbia–(BUSINESS WIRE)–Dexcom, Inc. (NASDAQ:DXCM), a global leader in real-time continuous glucose monitoring (rtCGM), is proud to announce that it is certified as a Great Place to Work® in Canada for 2022-23. Awarded by Great Place to Work Institute® Canada, the global authority on high-trust, high-performance workplace cultures, this prestigious certification is based on … [Read more…]

United States Medical Imaging Lens Markets, 2022-2027 – Surge in the Use of Medical Cameras and Microscopes for Neurosurgeries and Ophthalmology – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “US Medical Imaging Lens Market (2022-2027) by Product Application, Functional Application, End-Users, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering. The US Medical Imaging Lens Market is estimated to be USD 90.77 Mn in 2022 and is projected to reach USD 131.96 Mn by … [Read more…]

Cardiomyopathies Epidemiology Forecasts/Analysis Report 2021-2031: Focus on United States, France, Germany, Italy, Spain, UK, and Japan – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Cardiomyopathies Epidemiology Forecast, 2021-2031” report has been added to ResearchAndMarkets.com’s offering. The report includes a 10-year epidemiological forecast for the diagnosed prevalent cases of these cardiomyopathies segmented by subtype, sex, and age (under 18 years, 18-29 years, and by 10-year age groups for ages 30 years up to 80 years and older) in … [Read more…]

Ribbon Biolabs Establishes IP Portfolio with First Granted U.S. Patent Covering Fast, Cost-Effective, Long DNA Synthesis Technology

VIENNA, Austria–(BUSINESS WIRE)–Ribbon Biolabs, the DNA synthesis company, today announced that the U.S. Patent and Trademark Office has issued U.S. Patent US 2020283756 A1, covering Ribbon Biolabs’ novel method for synthesizing a double stranded polynucleotide, also known as DNA, using a diverse library of oligonucleotides. The patent is the first of its submitted patent applications … [Read more…]

CN Bio Opens New Laboratory Facilities to Extend Organ-on-a-chip Contract Research Services Capabilities

State-of-the-art laboratories significantly expand project capacity to meet increasing market demand for Organ-on-a-Chip research services CAMBRIDGE, England–(BUSINESS WIRE)–CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single-and multi-organ microphysiological systems (MPS), today announced the opening of new laboratory facilities at Cambridge Science Park, dedicated to its contract research services. The Company’s laboratory space … [Read more…]

Paragraf® Announces Innovate UK Biomedical Catalyst Grant Award to Develop the First Proof of Concept Graphene-based Diagnostic Test to Immediately Identify Patients Who Need an Antibiotic Treatment

The test will be the first in a pipeline of affordable, portable, easy-to-use, graphene-based IVD products, which will at least match the performance of the most advanced hospital laboratory, but at the point of care. CAMBRIDGESHIRE, England–(BUSINESS WIRE)–Paragraf, the first company in the world to deliver a scalable approach to graphene electronic device manufacturing, announces … [Read more…]